Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Are You Ready?
View:
Post by langosta on Feb 27, 2022 1:25pm

Are You Ready?

94 Monday Quotes to Start Your Week on a Positive Note
Comment by Oilminerdeluxe on Feb 27, 2022 1:35pm
Exciting few days for sure. Could be great things coming... or... https://tenor.com/HtHv.gif  I wonder what the heck the market wants from the company to be happy, but sure do hope that will happen.
Comment by langosta on Feb 27, 2022 6:56pm
With all of the positive anticipatory postings of the last few days; "Great Expectations", Are there any on here feeling just a tad nervous about the next few days 
Comment by Johnandrose22 on Feb 27, 2022 7:11pm
The recent corporate update kicked me a bit....the company had forecasted BTD late 2021 to early 2022, with Dr. Vera's now well known phrase strengthening confirmation...To have the recent corporate update seem to move the goal posts back to latter 2022 is of relative concern...I know that I have had my verbal hand slapped for thinking in these terms from certain posters...I'd be happy to ...more  
Comment by Kingpin68 on Feb 27, 2022 7:26pm
I didn't care for the BTD date being pushed back either, but it just must be updated guidance from the FDA. Possibly due to the first 12 patients being under treated ? In the meantime, as long as the quarterly data continues to improve it'll all be good. This week should be very interesting. GLTA
Comment by Johnandrose22 on Feb 27, 2022 7:46pm
Agree'd in full, Kingpin68....If the FDA provided guidance that included the first 12 undertreated patients which, in turn, postponed BTD until the end of the year I fully understand and am in support. For the newly minted research, experienced and corporate superstar to say "very soon" is, a bit, disappointing. IMO
Comment by 99942Apophis on Feb 27, 2022 8:08pm
My comment here isn't meant to insult but to point out a common trait people have and thats to not include the obvious into this trial. Time lines were moved out not because the company did or didn't do something but because Covid-19 greatly affected the enrollment & treatment of patients! Regardless of the initial under dosing we are seeing one patient after another hitting CR so yes ...more  
Comment by Johnandrose22 on Feb 27, 2022 8:17pm
Thank you, 99942apophis....from one gentleman to another...I,too. anticipate groundbreaking results...Here's to our common support and passion for this remarkable company and potential.
Comment by CancerSlayer on Feb 28, 2022 12:27am
  Well said...& what we do know is that Dr. Madzarevic (who joined Oct. 25, 2021) had nothing to do with the original timeline.  According to the Sept. 2021 company presentation, the projected BTD timeline was in the 1st half of 2022.  The most recent projected timeline is now in the latter part of 2022 (per the Feb 2022 company presentation).  It makes sense the timeline ...more  
Comment by jicoop on Feb 28, 2022 11:00am
See highlight and comments below: I had pointed this out to many here when the sites were announced, I did some research and found that many were offering multiple other choice trials for NMIBC , and some were sponsored or backed by BIG pharma, and who do you think these US site coordinators are being influenced by when it comes to suggesting a new trial for their patients, all just IMHO of ...more  
Comment by Infinity on Feb 28, 2022 3:49am
Hey Johnandrose22.  Which corporate update are you referring to?  That states that they are pushing the dates (Either clinical test results or BTD application with FDA)back to later part of 2022 ...,   Not sure where you are getting the data (recent update) from.  Am I the only one missing something alltogether?
Comment by Oilminerdeluxe on Feb 28, 2022 5:23am
Infinity, I suspect he means the next update that many of us think will come today or this week. Not a sure thing it will arrive but it might. I want some Vera magic!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250